Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cancer Pain × rofecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Osteoarthritis 1 Glioma 1 Cancer Pain 1 Brain Stem Neoplasms 1 Brain Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Sodium Bicarbonate 2 Morphine 2 rofecoxib 1 naloxegol 1 incobotulinumtoxinA 1 Oxcarbazepine 1 Methadone 1 Lenalidomide 1 Duration of Therapy 1 Donepezil 1 Cryotherapy 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00140894 2019-09-20

A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Merck Sharp & Dohme LLC

Phase 4 Terminated

Gastrointestinal

Cancer Pain, Osteoarthritis, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡